Takeda Pharmaceutical Co. Ltd. becomes the first one to get FDA approval for an oral drug targeted against rare form of non-small cell lung cancer. FDA has approved Exkivity (mobocertinib) for treatment…
Tag: New Lung Cancer Treatment
Chemotherapy and Immunotherapy Combination to Provide Effective Lung Cancer Treatment
According to a study published in Science Translational Medicine, a combination of two cancer treatments could provide effective treatment for lung cancer by targeting immune cells involved with formulation of tumors. The…
Indian Scientists Develop 3D Robotic Motion Phantom for Lung Cancer Treatment
Indian scientists have developed a novel three-dimensional robotic motion phantom that is capable of reproducing human lung motion. This robotic motion has been developed by Ashish Dutta, Professor at IIT Kanpur, Professor…
FDA Approves First Targeted Therapy for Lung Cancer with Specific Genetic Mutation
The U.S. Food and Drug Administration has approved Lumakras (sotorasib) as first treatment for non-small cell lung cancer patients whose tumors have specific type of genetic mutation called KRAS G12C. It is…
FDA Approves Libtayo as Monotherapy for Advanced NSCLC
Lung cancer is one of the leading causes of cancer-related deaths worldwide. In the year 2020, an estimated 225,000 new cases were diagnosed in the United States. Also, approximately 84% of all…
NICE Recommends Keytruda Plus Chemo for NSCLC Treatment
National Institute for Health and Care Excellence (NICE) has recommended Keytruda, alongside a combination of pemetrexed and platinum chemotherapy for first-line treatment of non-small cell lung cancer (NSCLC). This combination is recommended…
Study on New Combination of Immunotherapy Shows Promising Lung Cancer Treatment
In a recent study, researchers have established that a novel combination of two forms of immunotherapy can be highly effective in treatment of lung cancer. This new treatment uses one form of…
Lovelace Biomedical Provides New Formulation for Lung Cancer Treatment
Lung Cancer is a deadly disease taking away lives of hundreds of people every year. More and more studies and researches are being conducted in the arena for treatment of lung cancer….
Moffitt Researchers Develop Tool to Predict Lung Cancer Treatment
Choosing the right therapy for non-small cell lung cancer patient is not always an easy decision. Biomarkers can change during the therapy, making that treatment ineffective. The researchers at Moffitt Cancer Center…
New Study Identifies Drug to Boost Lung Cancer Survival Rates
A new study has found that a newly approved drug for leading form of cancer, lung cancer works to improve patient survival rate. The immunotherapy drug is called Tecentriq or atezolizumab. It…
New EarlyCDT-Lung Blood Test for Early Detection of Lung Cancer
Thanks to the pioneering new blood test, lung cancer could be detected earlier. This news comes as a fresh hope for lung cancer patients. The main reason behind the increasing number of…
Ramucirumab Injection in Combination with Erlotinib Gets FDA Approval for NSCLC
The Food and Drug Administration (FDA) has approved a 10mg/mL solution for first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) harboring EGFR exon 19 deletions or exon 21 mutations….